OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ALPMY

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Astellas Pharma (ALPMY) Earnings Date & Reports

Astellas Pharma Inc is a specialty global pharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALPMY is expected to report earnings to fall 35.47% to 16 cents per share on October 29

Astellas Pharma ALPMY Stock Earnings Reports

Q3'25

Est.

$0.16

Q2'25

Beat

by $0.12

Q1'25

Beat

by $41.06

Q4'24

Missed

by $0.41

Q3'24

Beat

by $0.01

The last earnings report on July 30 showed earnings per share of 25 cents, beating the estimate of 13 cents. With 119.59K shares outstanding, the current market capitalization sits at 26.55B.

View a ticker or compare two or three

Compare

ALPMY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALPMY
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALPMY showed earnings on July 30, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

N/A

Address

2-5-1, Nihonbashi-Honcho

Phone

+81 332443000

Employees

16243

Web

http://www.astellas.com